<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170611034452N12</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-20</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Tele-counselling on perinatal mental health during pandemics</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effectiveness of tele-counselling on perinatal mental health during SARS-COV-2 pandemics</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50289</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: Education 6 sessions, Twice a week, Randomization description: Randomization in this study is a simple randomization. It is a personal randomization unit. Layering (strata) is not done. Women under the affiliation of health care centres who fill informed consent forms mean that they agree to participate in the study. for the division of them into two groups of intervention and control, statistical software will usedThe tool used in randomization is Randomizer software (www.randomizer.org) which also performs random sequences. َAllocation concealment does not apply to this counselling intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: anxiety. Condition 2: depression. Condition 3: health anxiety.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention consists of 6 weekly group counselling sessions through virtual networks such as WhatsApp or Skype For 90 to 120 minutes                                                                                            Session 	Content:                                                                                              1-Training of how to prevent the COVID-19 and provision of information about the disease, familiarity with practical solutions to a healthy lifestyle according to the condition of women (healthy diet, exercise, adequate sleep), dysfunctional cognitions related to COVID-19, muscle relaxation technique, conscious eating technique, assignment                                      2-Reviewing assignments, defining mindfulness and its benefits in coping with COVID-19 anxiety, training and performing mindfulness on breathing and senses, expressing personal boundaries and limitations, assignments 3-Review of assignments, familiarity with the physical, mental, emotional, and behavioral symptoms of stress and anxiety, introduction of cognitive errors related to COVID-19 from Ellis and Beck's perspectives, training of ways to overcome pregnancy and postpartum fatigue, training of yoga and aerobic exercise to increase respiratory capacity, assignments           4-Review of assignments, seated meditation with focus on breathing, body sounds and thoughts (four-dimensional meditation), definition of autopilot mind, familiarity with coping styles in the face of stressors, assignments.                                                                                                     5-Reviewing assignments, re-discussing cognitive errors, expressing the disadvantages and advantages of worries and fears, promoting family relationships and making love to the fetus and neonate, defining the pleasant and unpleasant life events, and ways to change feelings and attitudes towards events, assignments.                                                          6-Accepting conditions and commitments by relying on self-care, being at the present (quitting daydreaming), discussing one’s fears about one’s vulnerability to disease, doing a body scan, reviewing and concluding. Intervention 2: Control group: There is no intervention for the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Atefeh Ahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haft Bagh Square</address>
        <city>kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5179</telephone>
        <email>atefeahmadi59@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Atefeh Ahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haft Bagh Square</address>
        <city>kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5179</telephone>
        <email>atefeahmadi59@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>satisfaction to participate in the study
being in a time period of 28 weeks of pregnancy to 28th postpartum day for women referring for perinatal services
Not consuming psychiatric medication</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>loss of pregnancy (fetal death)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41</hc_code>
      <hc_code>F32.8</hc_code>
      <hc_code>F45.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other anxiety disorders</hc_keyword>
      <hc_keyword>Other depressive episodes</hc_keyword>
      <hc_keyword>Other somatoform disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention consists of 6 weekly group counselling sessions through virtual networks such as WhatsApp or Skype For 90 to 120 minutes                                                                                            Session 	Content:                                                                                              1-Training of how to prevent the COVID-19 and provision of information about the disease, familiarity with practical solutions to a healthy lifestyle according to the condition of women (healthy diet, exercise, adequate sleep), dysfunctional cognitions related to COVID-19, muscle relaxation technique, conscious eating technique, assignment                                      2-Reviewing assignments, defining mindfulness and its benefits in coping with COVID-19 anxiety, training and performing mindfulness on breathing and senses, expressing personal boundaries and limitations, assignments 3-Review of assignments, familiarity with the physical, mental, emotional, and behavioral symptoms of stress and anxiety, introduction of cognitive errors related to COVID-19 from Ellis and Beck's perspectives, training of ways to overcome pregnancy and postpartum fatigue, training of yoga and aerobic exercise to increase respiratory capacity, assignments           4-Review of assignments, seated meditation with focus on breathing, body sounds and thoughts (four-dimensional meditation), definition of autopilot mind, familiarity with coping styles in the face of stressors, assignments.                                                                                                     5-Reviewing assignments, re-discussing cognitive errors, expressing the disadvantages and advantages of worries and fears, promoting family relationships and making love to the fetus and neonate, defining the pleasant and unpleasant life events, and ways to change feelings and attitudes towards events, assignments.                                                          6-Accepting conditions and commitments by relying on self-care, being at the present (quitting daydreaming), discussing one’s fears about one’s vulnerability to disease, doing a body scan, reviewing and concluding.</i_keyword>
      <i_keyword>Control group: There is no intervention for the control group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: Before and 3 weeks after intervention. Method of measurement: Modified to COVID-19 Hospital Depression and Anxiety Scale.</prim_outcome>
      <prim_outcome>Depression. Timepoint: Before and 3 weeks after intervention. Method of measurement: Modified to COVID-19-Hospital Depression and Anxiety Scale.</prim_outcome>
      <prim_outcome>Health anxiety. Timepoint: Before and 3 weeks after intervention. Method of measurement: Health anxiety questionnnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Kerman University of Medical Sciences</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-06-19</approval_date>
        <contact_name>Deputy of Research</contact_name>
        <contact_address>Haft Bagh Square kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
